Search All Content Point of Care Guidelines Search
Abdominal Fat and Risk
Acupuncture and Autonomic Remodeling
NSAIDs Increase Risk After MI
Obesity Paradox: Best Evidence Yet
Implantable Device Treats Hypertension
March 2012
Feb. 2012
Jan. 2012
Christopher Cannon, MD, FACC, editor-in-chief of CardioSource WorldNews, chose the EINSTEIN-PE trial as the most interesting late-breaking clinical trial (LBCT) presented at ACC.12. What was your favorite ACC.12 LBCT, and why? Join the April CardioSource WorldNews discussion!